2010
DOI: 10.1016/j.expneurol.2009.11.007
|View full text |Cite
|
Sign up to set email alerts
|

Sustained sensorimotor impairments after endothelin-1 induced focal cerebral ischemia (stroke) in aged rats

Abstract: Despite recent advances, stroke remains a leading cause of neurological disability with the vast majority of victims being the elderly, who exhibit more severe neurological deficits and a reduced capacity to recover from these disabilities in comparison to young stroke survivors. The objective of the present study was to develop a model of focal ischemic stroke in aged rats using endothelin-1 (ET-1) to produce low mortality rates as well as reliable, robust sensorimotor deficits that resemble functional impair… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

2
57
0

Year Published

2010
2010
2023
2023

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 59 publications
(59 citation statements)
references
References 63 publications
2
57
0
Order By: Relevance
“…One possibility is that the same aging mechanism may affect both brain and kidneys in some aged animals. For instance, overactivation of the endothelin system may damage both brain and kidneys by impairing microvascular function in these organs (Zhang et al 1994;Kuiper et al 2008;Seccia et al 2008;Soleman et al 2010). On the other hand, the impaired kidney function results in accumulation of metabolic toxic products which could impair brain function (e.g., cognition).…”
Section: Discussionmentioning
confidence: 99%
“…One possibility is that the same aging mechanism may affect both brain and kidneys in some aged animals. For instance, overactivation of the endothelin system may damage both brain and kidneys by impairing microvascular function in these organs (Zhang et al 1994;Kuiper et al 2008;Seccia et al 2008;Soleman et al 2010). On the other hand, the impaired kidney function results in accumulation of metabolic toxic products which could impair brain function (e.g., cognition).…”
Section: Discussionmentioning
confidence: 99%
“…7 ET-1 was injected at 0.5 μL/min by an infusion pump, and the needle was left in situ for 3 minutes after injection before being slowly removed. The dose of ET-1 for each injection site was 2 μL.…”
Section: Et-1 Stroke Modelmentioning
confidence: 99%
“…ET-1 can also be applied onto the cortical surface of the rat brain [12] , where it causes a critical reduction in CBF resulting in infarcts involving all layers of the neocortex. Variability of infarct size and greater accuracy of their location can be achieved by stereotactic intracortical injections of ET-1 into specific regions of the sensorimotor cortex, which produce impairment of the forelimb function [13] or sustained and robust sensorimotor deficits resembling functional impairments after stroke in humans [14] . In a comparative study of various ET-1 applications, the intracerebral injection into the forelimb motor region of the cortex and especially the combination of intracortical and intrastriatal injections produced more consistent injuries resulting in more consistent behavioral deficits than applications near the MCA or on the cortex.…”
Section: Introductionmentioning
confidence: 99%